Payment overview · 2025
General Payments
$32.73
1 reported records · 1 companies
Healthcare provider profile · identity verified
Jared West, D.O.
Allopathic & Osteopathic Physicians|Family Medicine · RICHFIELD, UT · NPI 1821418500
Verified facts
What the public records show
CMS Open Payments records show Jared West, D.O. received $32.73 in general payments during 2025 across 1 reported records.
Bayer Healthcare Pharmaceuticals Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $32.73 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $32.73 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Kerendia Normalized: kerendia |
Drug | Bayer Healthcare Pharmaceuticals Inc. | $32.73 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 425 | 110 |
| Levothyroxine Sodium | Levothyroxine Sodium | 384 | 85 |
| Omeprazole | Omeprazole | 329 | 82 |
| Amlodipine Besylate | Amlodipine Besylate | 311 | 77 |
| Losartan Potassium | Losartan Potassium | 304 | 73 |
| Gabapentin | Gabapentin | 250 | 49 |
| Pantoprazole Sodium | Pantoprazole Sodium | 239 | 50 |
| Lisinopril | Lisinopril | 219 | 60 |
| Trazodone Hcl | Trazodone Hcl | 217 | 46 |
| Metformin Hcl | Metformin Hcl | 167 | 37 |
| Tamsulosin Hcl | Tamsulosin Hcl | 165 | 39 |
| Potassium Chloride | Potassium Chloride | 161 | 47 |
| Metoprolol Succinate | Metoprolol Succinate | 148 | 34 |
| Furosemide | Furosemide | 138 | 40 |
| Escitalopram Oxalate | Escitalopram Oxalate | 126 | 29 |
| Hydrochlorothiazide | Hydrochlorothiazide | 122 | 31 |
| Pravastatin Sodium | Pravastatin Sodium | 118 | 36 |
| Simvastatin | Simvastatin | 111 | 31 |
| Fluoxetine Hcl | Fluoxetine Hcl | 104 | 23 |
| Fluticasone Propionate | Fluticasone Propionate | 98 | 34 |
| Pregabalin | Pregabalin | 97 | 13 |
| Lorazepam | Lorazepam | 95 | 16 |
| Tramadol Hcl | Tramadol Hcl | 95 | 24 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 92 | 24 |
| Duloxetine Hcl | Duloxetine Hcl | 89 | 15 |
| Eliquis | Apixaban | 78 | 17 |
| Alendronate Sodium | Alendronate Sodium | 75 | 19 |
| Zolpidem Tartrate | Zolpidem Tartrate | 72 | suppressed |
| Estradiol | Estradiol | 70 | 17 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 67 | 18 |
| Sertraline Hcl | Sertraline Hcl | 66 | 14 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 62 | 17 |
| Metformin Hcl Er | Metformin Hcl | 61 | 11 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 59 | 25 |
| Jardiance | Empagliflozin | 59 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 58 | 17 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 57 | 17 |
| Alprazolam | Alprazolam | 55 | 11 |
| Citalopram Hbr | Citalopram Hydrobromide | 54 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 50 | 11 |
| Prednisone | Prednisone | 50 | 16 |
| Clonazepam | Clonazepam | 45 | suppressed |
| Ezetimibe | Ezetimibe | 45 | 11 |
| Finasteride | Finasteride | 44 | suppressed |
| Carvedilol | Carvedilol | 43 | 12 |
| Synthroid | Levothyroxine Sodium | 43 | 11 |
| Metoprolol Tartrate | Metoprolol Tartrate | 42 | 13 |
| Celecoxib | Celecoxib | 41 | suppressed |
| Famotidine | Famotidine | 41 | 12 |
| Meloxicam | Meloxicam | 41 | 13 |
| Spironolactone | Spironolactone | 41 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 39 | suppressed |
| Allopurinol | Allopurinol | 38 | 13 |
| Ozempic | Semaglutide | 38 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 37 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 35 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 35 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 35 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 34 | suppressed |
| Xarelto | Rivaroxaban | 34 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 33 | 11 |
| Ropinirole Hcl | Ropinirole Hcl | 33 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 33 | 28 |
| Diclofenac Sodium | Diclofenac Sodium | 30 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 30 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 29 | suppressed |
| Aripiprazole | Aripiprazole | 28 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 28 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 28 | suppressed |
| Torsemide | Torsemide | 27 | suppressed |
| Glimepiride | Glimepiride | 26 | suppressed |
| Mounjaro | Tirzepatide | 26 | suppressed |
| Trulicity | Dulaglutide | 25 | suppressed |
| Valsartan | Valsartan | 25 | suppressed |
| Eszopiclone | Eszopiclone | 23 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 23 | suppressed |
| Cephalexin | Cephalexin | 22 | 17 |
| Lovastatin | Lovastatin | 22 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 22 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 21 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 20 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 20 | 13 |
| Januvia | Sitagliptin Phosphate | 19 | suppressed |
| Sotalol | Sotalol Hcl | 19 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 18 | suppressed |
| Bupropion Xl | Bupropion Hcl | 18 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 18 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 17 | 16 |
| Naproxen | Naproxen | 17 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 17 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 16 | 14 |
| Sumatriptan Succinate | Sumatriptan Succinate | 16 | suppressed |
| Amoxicillin | Amoxicillin | 15 | 15 |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Ibuprofen | Ibuprofen | 15 | suppressed |
| Levofloxacin | Levofloxacin | 15 | suppressed |
| Loperamide | Loperamide Hcl | 15 | suppressed |
| Np Thyroid | Thyroid,pork | 15 | suppressed |
| Ondansetron Odt | Ondansetron | 15 | suppressed |
| Tradjenta | Linagliptin | 15 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 14 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 14 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 14 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 14 | suppressed |
| Risperidone | Risperidone | 14 | suppressed |
| Sucralfate | Sucralfate | 14 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 13 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 13 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 13 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 13 | suppressed |
| Irbesartan | Irbesartan | 13 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 13 | suppressed |
| Primidone | Primidone | 13 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 13 | suppressed |
| Ulticare Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 12 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Bumetanide | Bumetanide | 12 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 12 | suppressed |
| Glipizide | Glipizide | 12 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 12 | suppressed |
| Lansoprazole | Lansoprazole | 12 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 12 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 12 | suppressed |
| Colchicine | Colchicine | 11 | suppressed |
| Diazepam | Diazepam | 11 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 11 | suppressed |
| Novolog Flexpen | Insulin Aspart | 11 | suppressed |
| Soliqua 100-33 | Insulin Glargine/Lixisenatide | 11 | suppressed |
| Topiramate | Topiramate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $32.73 · 1 records | Bayer Healthcare Pharmaceuticals Inc. | Kerendia | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error